Periodic Reporting for period 1 - EPIGEN (EPIGEN: A New Predictive Response Test for Non Small Cells Lung Cancer Treatment)

The EPiGen Project final goal is the commercialization of the EPiGen test under CE-IVD mark as a new predictive response test to lead clinicians towards Non Small Cell Lung Cancer (NSCLC, the 80% of lung cancer diagnosed cases) personalized treatment. The key of the test is...